PERSONALIS INC (PSNL) Stock Overview
NASDAQ:PSNL - US71535D1063 - Common Stock
PSNL Key Statistics, Chart & Performance
The current stock price of PSNL is 4.78 USD. In the past month the price decreased by -14.49%. In the past year, price decreased by -12.13%.
PSNL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 22.3 | 184.32B | ||
| DHR | DANAHER CORP | 27.22 | 146.79B | ||
| A | AGILENT TECHNOLOGIES INC | 21.78 | 33.72B | ||
| IQV | IQVIA HOLDINGS INC | 16.46 | 32.10B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 31.42 | 26.48B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 35.34 | 17.69B | ||
| WAT | WATERS CORP | 24.09 | 17.54B | ||
| ILMN | ILLUMINA INC | 23.93 | 15.30B | ||
| ICLR | ICON PLC | 13.15 | 13.53B | ||
| MEDP | MEDPACE HOLDINGS INC | 35.2 | 13.30B | ||
| TEM | TEMPUS AI INC | N/A | 12.72B | ||
| QGEN | QIAGEN N.V. | 20.42 | 10.39B |
Related stock screener links
About PSNL
Company Profile
Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The company is headquartered in Fremont, California and currently employs 229 full-time employees. The company went IPO on 2019-06-20. The Company’s advanced genomic sequencing and analytics support the development of personalized cancer vaccines and other cancer immunotherapies. Its products include NeXT Personal, ImmunoI DNeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). NeXT Personal is a tumor-informed liquid biopsy test for the detection of minimal residual disease (MRD) and recurrence in cancer. NeXT Dx is a comprehensive tumor profiling test that is used to help select therapy for a cancer patient and identify potential clinical trials for a patient. The firm performed WGS on human samples for research projects, such as population sequencing initiatives. The Company’s tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and the development of personalized cancer therapies.
Company Info
PERSONALIS INC
6600 Dumbarton Circle
Fremont CALIFORNIA 94025 US
CEO: John West
Employees: 229
Phone: 16507521300
PERSONALIS INC / PSNL FAQ
What is the stock price of PERSONALIS INC today?
The current stock price of PSNL is 4.78 USD. The price decreased by -2.05% in the last trading session.
What is the ticker symbol for PERSONALIS INC stock?
The exchange symbol of PERSONALIS INC is PSNL and it is listed on the Nasdaq exchange.
On which exchange is PSNL stock listed?
PSNL stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for PERSONALIS INC stock?
14 analysts have analysed PSNL and the average price target is 7.2 USD. This implies a price increase of 50.71% is expected in the next year compared to the current price of 4.78. Check the PERSONALIS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PERSONALIS INC worth?
PERSONALIS INC (PSNL) has a market capitalization of 423.89M USD. This makes PSNL a Small Cap stock.
How many employees does PERSONALIS INC have?
PERSONALIS INC (PSNL) currently has 229 employees.
What are the support and resistance levels for PERSONALIS INC (PSNL) stock?
PERSONALIS INC (PSNL) has a support level at 4.74 and a resistance level at 4.83. Check the full technical report for a detailed analysis of PSNL support and resistance levels.
Is PERSONALIS INC (PSNL) expected to grow?
The Revenue of PERSONALIS INC (PSNL) is expected to decline by -12.47% in the next year. Check the estimates tab for more information on the PSNL EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy PERSONALIS INC (PSNL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PSNL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PSNL, evaluating the profitability, health, valuation and growth aspects
- PERSONALIS INC (PSNL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PERSONALIS INC (PSNL) Sales and EPS estimates to see what analysts future expectations are.
- PERSONALIS INC (PSNL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PERSONALIS INC (PSNL) Insider and Institutional Ownership to learn about the owners and their transactions.
- PERSONALIS INC (PSNL) Stock Chart to make your own analysis
- PERSONALIS INC (PSNL) Latest news and press-releases to stay up to date.
Does PERSONALIS INC (PSNL) stock pay dividends?
PSNL does not pay a dividend.
When does PERSONALIS INC (PSNL) report earnings?
PERSONALIS INC (PSNL) will report earnings on 2025-11-04, after the market close.
What is the Price/Earnings (PE) ratio of PERSONALIS INC (PSNL)?
PERSONALIS INC (PSNL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.28).
What is the Short Interest ratio of PERSONALIS INC (PSNL) stock?
The outstanding short interest for PERSONALIS INC (PSNL) is 12.36% of its float. Check the ownership tab for more information on the PSNL short interest.
PSNL Technical Analysis
PSNL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to PSNL. While PSNL seems to be doing ok healthwise, there are quite some concerns on its profitability.
PSNL Financial Highlights
Over the last trailing twelve months PSNL reported a non-GAAP Earnings per Share(EPS) of -1.28. The EPS increased by 15.79% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -35.3% | ||
| ROE | -47.85% | ||
| Debt/Equity | 0 |
PSNL Forecast & Estimates
14 analysts have analysed PSNL and the average price target is 7.2 USD. This implies a price increase of 50.71% is expected in the next year compared to the current price of 4.78.
For the next year, analysts expect an EPS growth of 28.48% and a revenue growth -12.47% for PSNL